The purpose of this research study is to examine the effectiveness of the nutritional supplement, fisetin, in improving physical function in women treated for breast cancer.
In this study, we want to see how patients with metastatic non-small cell lung cancer do with two treatments: ivonescimab and chemotherapy. We are comparing these treatments to find out which one helps patients more.
To evaluate the safety, optimum drug usage, and anti tumor activity for the drug BDTX-1535.
Are you an adult diagnosed with multiple myeloma within the last 5 years? If so, you may be able to participate in our research study to help improve how myeloma is diagnosed. Tell us about your experience, what went well, and what didn't, so we can make things better for future myeloma patients. Your voice matters! Compensation will be provided.
Do you identify as Black or African-American? Have you been diagnosed with colon cancer, rectal cancer, or colorectal cancer? If so, you may be able to take part in a study to see if an exercise program can help with cancer side effects and overall quality of life. Compensation provided,
In this study, we will find out if a new experimental pill called ropidoxuridine can help improve the treatment of a brain cancer called IDH-Wildtype Glioblastoma. We want to see how well it works when used with radiation therapy.
In this study, we want to find out if a new drug called Soquelitinib (also known as CPI-818) can be safely given to people. We are also checking to see if it can help treat a type of cancer called relapsed peripheral T-cell lymphoma (PTCL).
In this study, we want to find a better treatment for advanced melanoma. We want to see how well two different drugs work compared to the regular treatment.
The purpose of this research study is to improve cancer care for patients whose treatment outcomes have led to challenges in their quality of life. The study is randomized into 2 groups. Group 1 will receive a pre-rehabilitation referral in addition to their standard of care cancer treatment and Group 2 will resume their standard of care cancer treatment. Regardless of the group you are assigned to, all participants will answer questionnaires at baseline and at their 3-month follow-up.
The purpose of this study is to test the safety and effectiveness of the test drug IMGN151-1001 on your cancer.